div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: taiwan-pharmaorgtperglycaemic hyperosmolar non-ketotic syn- drome Drugs 383 P462-472 1989 7 JA Davidson Recombinant DNA human insulin clinical experience with the transfer src=https:reader033fdocumentocomreader033viewer202205311760996b1c911f51255f6f9482html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: taiwan-pharmaorgtperglycaemic hyperosmolar non-ketotic syn- drome Drugs 383 P462-472 1989 7 JA Davidson Recombinant DNA human insulin clinical experience with the transfer src=https:reader033fdocumentocomreader033viewer202205311760996b1c911f51255f6f9482html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: taiwan-pharmaorgtperglycaemic hyperosmolar non-ketotic syn- drome Drugs 383 P462-472 1989 7 JA Davidson Recombinant DNA human insulin clinical experience with the transfer src=https:reader033fdocumentocomreader033viewer202205311760996b1c911f51255f6f9482html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: taiwan-pharmaorgtperglycaemic hyperosmolar non-ketotic syn- drome Drugs 383 P462-472 1989 7 JA Davidson Recombinant DNA human insulin clinical experience with the transfer src=https:reader033fdocumentocomreader033viewer202205311760996b1c911f51255f6f9482html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: taiwan-pharmaorgtperglycaemic hyperosmolar non-ketotic syn- drome Drugs 383 P462-472 1989 7 JA Davidson Recombinant DNA human insulin clinical experience with the transfer...